Literature DB >> 9815237

Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group.

K J Mertz1, D Trees, W C Levine, J S Lewis, B Litchfield, K S Pettus, S A Morse, M E St Louis, J B Weiss, J Schwebke, J Dickes, R Kee, J Reynolds, D Hutcheson, D Green, I Dyer, G A Richwald, J Novotny, I Weisfuse, M Goldberg, J A O'Donnell, R Knaup.   

Abstract

To determine the etiology of genital ulcers and to assess the prevalence of human immunodeficiency virus (HIV) infection in ulcer patients in 10 US cities, ulcer and serum specimens were collected from approximately 50 ulcer patients at a sexually transmitted disease clinic in each city. Ulcer specimens were tested using a multiplex polymerase chain reaction assay to detect Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus (HSV); sera were tested for antibody to HIV. H. ducreyi was detected in ulcer specimens from patients in Memphis (20% of specimens) and Chicago (12%). T. pallidum was detected in ulcer specimens from every city except Los Angeles (median, 9% of specimens; range, 0%-46%). HSV was detected in >/=50% of specimens from all cities except Memphis (42%). HIV seroprevalence in ulcer patients was 6% (range by city, 0%-18%). These data suggest that chancroid is prevalent in some US cities and that persons with genital ulcers should be a focus of HIV prevention activities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815237     DOI: 10.1086/314502

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Description of a nonlethal herpes simplex virus type 1 glycoprotein D deletion mutant affecting a site frequently used for PCR.

Authors:  P V Coyle; S Jain; D Wyatt; C McCaughey; H J O'Neill
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  The Use of Molecular Techniques for the Diagnosis and Epidemiologic Study of Sexually Transmitted Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

Review 3.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Public Health Strategies to Prevent Genital Herpes: Where Do We Stand?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

Review 5.  Comparison of Diagnostic Accuracy of PCR Targeting the 47-Kilodalton Protein Membrane Gene of Treponema pallidum and PCR Targeting the DNA Polymerase I Gene: Systematic Review and Meta-analysis.

Authors:  Angèle Gayet-Ageron; Christophe Combescure; Stephan Lautenschlager; Béatrice Ninet; Thomas V Perneger
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

Review 6.  [Genital herpes].

Authors:  C J Adam; M Staehler; W Khoder; C Stief
Journal:  Urologe A       Date:  2006-12       Impact factor: 0.639

7.  Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents.

Authors:  Christine Johnston; Amalia Magaret; Pavitra Roychoudhury; Alexander L Greninger; Anqi Cheng; Kurt Diem; Matthew P Fitzgibbon; Meei-Li Huang; Stacy Selke; Jairam R Lingappa; Connie Celum; Keith R Jerome; Anna Wald; David M Koelle
Journal:  Virology       Date:  2017-07-13       Impact factor: 3.616

8.  Regulation of expression of the Haemophilus ducreyi LspB and LspA2 proteins by CpxR.

Authors:  Maria Labandeira-Rey; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

9.  The Haemophilus ducreyi Fis protein is involved in controlling expression of the lspB-lspA2 operon and other virulence factors.

Authors:  Maria Labandeira-Rey; Dana A Dodd; Chad A Brautigam; Kate R Fortney; Stanley M Spinola; Eric J Hansen
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

10.  Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.

Authors:  Sita Awasthi; John W Balliet; Jessica A Flynn; John M Lubinski; Carolyn E Shaw; Daniel J DiStefano; Michael Cai; Martha Brown; Judith F Smith; Rose Kowalski; Ryan Swoyer; Jennifer Galli; Victoria Copeland; Sandra Rios; Robert C Davidson; Maya Salnikova; Susan Kingsley; Janine Bryan; Danilo R Casimiro; Harvey M Friedman
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.